Contact Us
enptesit

News & Insight

•2026-05-11•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by Health Canada.

According to the forecast report of Data Bridge Market Research, the North America is the largest market of global advanced wound care market. The CAGR is 6.4% in the forecast period from 2020 to 2027, and it is expected to reach 4.6 billion dollars by 2027.
Read More
•2026-05-11•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by ThaiFDA.

According to the International Diabetes Federation (IDF), there are approximately 6.36 million people with diabetes in Thailand. However, due to the lack of effective and cost-effective drugs or medical devices for chronic wounds, the annual burden of wound care is currently estimated to exceed USD 700 million (Int Wound J. 2023 Nov 14;20(10):3935–3938).
Read More
•2026-04-10•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by AMMPS Morocco.

Morocco’s advanced wound care market is growing steadily, driven by rising chronic wounds and diabetes. As of 2025, 2.88 million people live with diabetes (IDF Diabetes Atlas 11th Edition). With increasing diabetes prevalence, expanding healthcare infrastructure, and a growing trend toward home care, demand for advanced wound care products in both clinical and home settings continues to rise.
Read More
•2026-03-12•

EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management.

Global healthcare expenditure in the wound care market has reached $300 billion, with the U.S., EU, and China serving as the primary markets. Notably, there remains a significant unmet medical need for chronic non-healing wounds, for which no truly effective drugs or medical devices currently exist.
Read More
•2026-02-22•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia.

According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, 11th Edition, in Colombia, approximately 3.0 million adults currently live with diabetes, representing a prevalence rate of 8.4%, with projections indicating the number will climb to 4.3 million by 2050. Market data further show that Colombia’s advanced wound care (AWC) markets are growing steadily. In Colombia, the AWC market was valued at approximately USD 61.7 million in 2023 and is projected to reach USD 92.4 million by 2030, with a CAGR of 5.9%.
Read More
•2026-01-31•

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia.

According to the International Diabetes Federation (IDF) Diabetes Atlas 2025, 11th Edition, in Colombia, approximately 3.0 million adults currently live with diabetes, representing a prevalence rate of 8.4%, with projections indicating the number will climb to 4.3 million by 2050. Market data further show that Colombia’s advanced wound care (AWC) markets are growing steadily. In Colombia, the AWC market was valued at approximately USD 61.7 million in 2023 and is projected to reach USD 92.4 million by 2030, with a CAGR of 5.9%.
Read More
•2026-01-05•

Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt.

With a population of approximately 108 million and a diabetic population of approximately 11 million, Egypt's wound care market has great potential.
Read More
•2025-12-19•

Bonvadis® topical cream received medical device import license for all indications in wounds for India.

According to Invest India, the country’s medical device market is valued at approximately USD 11 billion and is one of the fastest-growing among emerging markets. With a projected 15% CAGR (2.5 times the global average) the market is expected to reach USD 50 billion by 2030.
Read More
•2025-11-11•

The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Health Canada.

According to the forecast report of Data Bridge Market Research, the North America is the largest market of global advanced wound care market. The CAGR is 6.4% in the forecast period from 2020 to 2027, and it is expected to reach 4.6 billion dollars by 2027.
Read More
1 2 3